Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using
exemestane plus goserelin may fight breast cancer by reducing the production of estrogen.
PURPOSE: Phase II trial to study the effectiveness of exemestane and goserelin in treating
premenopausal women who have metastatic breast cancer that has not responded to previous
tamoxifen.
Phase:
Phase 2
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health